Amiloidózis: vizsgálatok itt: Új-Zéland
3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Auckland, Christchurch
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Auckland, Christchurch, Hamilton
- Életkor
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - 2/3. fázisCsak meghívásosLong-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
- Where
- Auckland
- Életkor
- 18 év and over
- People
- 72 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT05697861 · EU 2023-507385-11-00